These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


220 related items for PubMed ID: 9255293

  • 1. Doxazosin in men with lower urinary tract symptoms: urodynamic evaluation at 15 months.
    Gerber GS, Contreras BA, Zagaja GP, Kim JH, Steinberg GD, Rukstalis DB.
    Urology; 1997 Aug; 50(2):229-33. PubMed ID: 9255293
    [Abstract] [Full Text] [Related]

  • 2. An observational urodynamic evaluation of men with lower urinary tract symptoms treated with doxazosin.
    Gerber GS, Kim JH, Contreras BA, Steinberg GD, Rukstalis DB.
    Urology; 1996 Jun; 47(6):840-4. PubMed ID: 8677574
    [Abstract] [Full Text] [Related]

  • 3. Use of novel urodynamic parameters, detrusor contraction duration and detrusor contraction index, in men with lower urinary tract symptoms.
    Turner CD, Kuznetsov D, Contreras BA, Gerber GS.
    Tech Urol; 1998 Sep; 4(3):136-40. PubMed ID: 9800891
    [Abstract] [Full Text] [Related]

  • 4. Ambulatory urodynamic evaluation of men with lower urinary tract symptoms treated with doxazosin.
    Gerber GS, Contreras BA, Rukstalis DB.
    Tech Urol; 1997 Sep; 3(3):164-7. PubMed ID: 9422449
    [Abstract] [Full Text] [Related]

  • 5. Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder.
    Lee JY, Kim HW, Lee SJ, Koh JS, Suh HJ, Chancellor MB.
    BJU Int; 2004 Oct; 94(6):817-20. PubMed ID: 15476515
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of tamsulosin hydrochloride compared to doxazosin in the treatment of Indonesian patients with lower urinary tract symptoms due to benign prostatic hyperplasia.
    Rahardjo D, Soebadi DM, Sugandi S, Birowo P, Djati W, Wahyudi I.
    Int J Urol; 2006 Nov; 13(11):1405-9. PubMed ID: 17083392
    [Abstract] [Full Text] [Related]

  • 7. Urodynamic and clinical effects of terazosin therapy in symptomatic patients with and without bladder outlet obstruction: a stratified analysis.
    Witjes WP, Rosier PF, Caris CT, Debruyne FM, de la Rosette JJ.
    Urology; 1997 Feb; 49(2):197-205; discussion 205-6. PubMed ID: 9037281
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up.
    Hamann MF, Naumann CM, Seif C, van der Horst C, Jünemann KP, Braun PM.
    Eur Urol; 2008 Oct; 54(4):902-7. PubMed ID: 18502565
    [Abstract] [Full Text] [Related]

  • 11. Comparative efficacy of two alpha-adrenoreceptor antagonists, doxazosin and alfuzosin, in patients with lower urinary tract symptoms from benign prostatic enlargement.
    de Reijke TM, Klarskov P.
    BJU Int; 2004 Apr; 93(6):757-62. PubMed ID: 15049986
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.
    Dmochowski R, Roehrborn C, Klise S, Xu L, Kaminetsky J, Kraus S.
    J Urol; 2010 Mar; 183(3):1092-7. PubMed ID: 20092847
    [Abstract] [Full Text] [Related]

  • 14. The resolution of detrusor over activity after medical and surgical treatment in patients with bladder outlet obstruction.
    Sriplakich S, Promwatcharanon K.
    J Med Assoc Thai; 2007 Nov; 90(11):2326-31. PubMed ID: 18181315
    [Abstract] [Full Text] [Related]

  • 15. [Doxazosin in the gastrointestinal therapeutic system (GITS) and doxazosin standard in patients with benign prostatic hyperplasia. Double-blind trial of efficacy and tolerability].
    Gratzke P, Kirby RS.
    Fortschr Med Orig; 2000 Jul 27; 118 Suppl 2():83-92. PubMed ID: 15700491
    [Abstract] [Full Text] [Related]

  • 16. Transurethral microwave therapy in 200 patients with a minimum followup of 2 years: urodynamic and clinical results.
    Thalmann GN, Mattei A, Treuthardt C, Burkhard FC, Studer UE.
    J Urol; 2002 Jun 27; 167(6):2496-501. PubMed ID: 11992066
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A comparison of four different alpha1-blockers in benign prostatic hyperplasia patients with and without diabetes.
    Bozlu M, Ulusoy E, Cayan S, Akbay E, Görür S, Akbay E.
    Scand J Urol Nephrol; 2004 Jun 27; 38(5):391-5. PubMed ID: 15764250
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.